Pay in 4 interest-free payments of $5.56 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
The plaintiffs have relied on five expert witnesses to testify on topics like gastroparesis and gallbladder injury in support of their claims against GLP-1 manufacturers
LifeVantage clinical study analysis LifeVantage cites two 12-week human clinical studies to support their product claims
The researchers analyzed data from 2,185 patients with obesity who underwent bariatric surgery at three hospitals in Indiana between 2018 and 2023, of whom 14.8% used a GLP-1 receptor agonist in the year before their surgery
It occurred in 20.9% of TRIUMPH-4 participants and was observed in TRIUMPH-1 as well, confirming it's not a TRIUMPH-4 artifact
Because new Phase 3 obesity results announced in May 2026 drew major attention to its weight-loss potential
US$ 22.54
US$ 25.80
US$ 21.15
US$ 24.78
